Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
| Purity | ≥70% |
|---|---|
| Formula | C16H14N2O4 |
| Formula Wt. | 298.29 |
| Appearance | Red Powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Taxane synthesis intermediate.
TxA2 antagonist.
Pim-1 inhibitor.
Vitamin B, required for formation of NAD and NA...
Folic acid derivative
5-HT2/3/6/7, D2/3/4, histamine H1, α1-adrenerg...
Endogenous peptide hormone, involved in cell gr...
Synthetic steroid hormone; AR agonist, ER and P...
NSAID; COX-1/2 inhibitor, potential K+ channel ...
Pyrimidine analog; inhibits thymidylate synthas...
c-Raf, Ret, VEGFR2 inhibitor, potential STAT3/5...
Naturally produced ITC, sulfonyl analog of sulf...
Cyclic peptide mycotoxin produced by Alternaria...
KRAS inhibitor
Nitrosourea, DNA cross-linker.
DNA-PK inhibitor.
Amino amide; voltage-gated Na+, BK/SK, Kv1, Kv3...
Sesquiterpene lactone derived from Artemesia.
NSAID; COX inhibitor and HS-releasing agent.
Polyphenolic hydroxystilbene, resveratrol deri...